undamentalytics Newsletter
Sign in

Datameds AI, Inc. revenue

Datameds AI, Inc.'s revenue was $23.3m in fiscal 2025, up 28.7% on the year before. Over the last twelve months it was $8.0m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2024Dec 20242025Dec 2025LTMJun 2026
Revenue18238
Growth on the year before—+28.7%—
Gross profit2−6−7
Gross margin9.7%−27.5%−90.6%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Products $21.9M 93.7% ▲ 23.8%
Pharmacy Retail Sales $865,695 3.7% ▲ 145.7%
Third Party Logistics Services $603,417 2.6% ▲ 463.9%

From Datameds AI, Inc.'s 10-K filed March 20, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Technology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Datameds AI, Inc. $8.0m -78.2% —
Mobile-health Network Solutions $7.7m 1.2% —
Dariohealth Corp. $21.0m -22.6% -7.6%
Scworx Corp. $2.9m 3.1% -9.9%
Healthcare Triangle, Inc. $25.7m 116.4% -14.9%
Firefly Neuroscience, Inc. $1.8m 320.3% -41.3%

Compare with peers

Head to head: MEDS vs MNDRDRIO vs MEDSMEDS vs WORX

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Datameds AI, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Datameds AI, Inc.